Cilnidipine 20mg & Telmisartan 40mg ''''

Hypertension, commonly known as high blood pressure, has emerged as one of the most prevalent lifestyle‑related health conditions in India. Rapid urbanisation, dietary changes, stress, sedentary habits, obesity, and genetic predisposition have significantly increased the burden of cardiovascular diseases across the country. Uncontrolled blood pressure is a major risk factor for heart attack, stroke, kidney failure, and other serious complications. Effective and sustained blood pressure control is therefore essential for long‑term cardiovascular protection.

CIDNITAB T 20/40 is a clinically proven combination of Cilnidipine 20 mg and Telmisartan 40 mg, designed to provide comprehensive and long‑lasting blood pressure control. This dual‑action antihypertensive therapy targets multiple mechanisms involved in hypertension, offering improved efficacy, better tolerability, and enhanced patient compliance.

Manufactured with strict quality standards, CIDNITAB T 20/40 is commonly prescribed by physicians for patients with uncontrolled or difficult‑to‑manage hypertension, especially those who require combination therapy for optimal results.

Understanding Hypertension

What Is Hypertension?

Hypertension is a chronic medical condition in which the force of blood against the artery walls remains persistently elevated. Blood pressure is measured in two values:

• Systolic Blood Pressure (SBP): Pressure when the heart contracts

• Diastolic Blood Pressure (DBP): Pressure when the heart relaxes

A sustained reading of 140/90 mmHg or higher is generally considered hypertension.

Why Is Hypertension Dangerous?

Uncontrolled hypertension silently damages vital organs over time. Many patients remain asymptomatic until complications develop, earning it the name "the silent killer." Long‑standing high blood pressure can lead to:

• Heart attack and heart failure

• Stroke and brain haemorrhage

• Chronic kidney disease

• Vision loss

• Peripheral vascular disease

Effective and early management is essential to prevent these complications.

About CIDNITAB T 20/40

Composition

• Cilnidipine 20 mg

• Telmisartan 40 mg

Therapeutic Class

• Calcium Channel Blocker (CCB) + Angiotensin II Receptor Blocker (ARB)

Indication

CIDNITAB T 20/40 tablets are indicated for the treatment of hypertension, particularly in patients who do not achieve adequate blood pressure control with monotherapy.

How CIDNITAB T 20/40 Works

CIDNITAB T 20/40 offers dual‑action blood pressure control by combining two complementary antihypertensive agents.

Role of Cilnidipine

Cilnidipine is a unique, newer‑generation calcium channel blocker that blocks both L‑type and N‑type calcium channels.

• L‑type calcium channel blockade relaxes smooth muscles of blood vessels, reducing vascular resistance

• N‑type calcium channel blockade suppresses sympathetic nerve activity, leading to reduced heart rate response and lower stress on the cardiovascular system

This dual blockade results in:

• Effective vasodilation

• Reduced arterial stiffness

• Minimal reflex tachycardia compared to older CCBs

Role of Telmisartan

Telmisartan belongs to the angiotensin II receptor blocker (ARB) class.

• Blocks the action of angiotensin II, a potent vasoconstrictor

• Prevents narrowing of blood vessels

• Reduces aldosterone secretion, helping regulate salt and water balance

Telmisartan also offers renal protection, especially in patients with diabetes and hypertension.

Synergistic Effect

Together, Cilnidipine and Telmisartan:

• Reduce peripheral vascular resistance

• Improve overall blood flow

• Provide sustained 24‑hour blood pressure control

• Lower both systolic and diastolic blood pressure

Benefits of CIDNITAB T 20/40

Effective Blood Pressure Control

CIDNITAB T 20/40 ensures consistent and long‑lasting blood pressure reduction throughout the day.

Dual Mechanism of Action

Targets multiple pathways responsible for hypertension, offering superior efficacy compared to single‑drug therapy.

Reduced Cardiovascular Risk

By maintaining optimal blood pressure levels, CIDNITAB T 20/40 helps reduce the risk of:

• Heart attack

• Stroke

• Heart failure

Kidney Protection

Telmisartan provides additional renal protection, making the combination suitable for hypertensive patients with diabetes or early kidney involvement.

Improved Compliance

Once‑daily dosing simplifies treatment and improves patient adherence.

Minimal Side Effects

Cilnidipine causes less reflex tachycardia and peripheral edema compared to older calcium channel blockers.

CIDNITAB T 20/40 in Special Patient Groups

Patients with Uncontrolled Hypertension

Ideal for individuals whose blood pressure remains high despite single‑drug therapy.

Diabetic Patients

Helps manage blood pressure while protecting kidney function.

Elderly Patients

Offers smooth blood pressure control with better tolerability under medical supervision.

Patients at Risk of Target Organ Damage

Prevents damage to heart, kidneys, brain, and blood vessels caused by prolonged hypertension.

Dosage and Administration

• Usually taken once daily, preferably at the same time each day

• Can be taken with or without food

• Dose should be strictly as prescribed by the physician

Dose Adjustment

• May be required in patients with liver impairment

• Not recommended without medical advice in severe hepatic disease

Safety Profile and Tolerability

CIDNITAB T 20/40 is generally well tolerated when taken under medical supervision.

Common Mild Side Effects

• Dizziness

• Headache

• Fatigue

• Mild ankle swelling

These effects are usually transient and subside with continued therapy.

Less Common Side Effects

• Low blood pressure

• Palpitations

• Gastrointestinal discomfort

Patients should consult a doctor if symptoms persist.

Precautions and Warnings

• Not recommended during pregnancy and breastfeeding

• Regular blood pressure monitoring is advised

• Avoid potassium supplements unless prescribed

• Caution in patients with liver disorders

• Inform the physician about all ongoing medications to avoid interactions

Drug Interactions

CIDNITAB T 20/40 may interact with:

• Potassium‑sparing diuretics

• Potassium supplements

• Other antihypertensive medications

• NSAIDs (may reduce antihypertensive effect)

Always inform your healthcare provider about all medicines you are taking.

Lifestyle Measures to Enhance Effectiveness

Medication works best when combined with healthy lifestyle practices:

• Low‑salt, heart‑healthy diet

• Regular physical activity

• Weight management

• Stress reduction

• Avoid smoking and excessive alcohol

These measures significantly improve long‑term blood pressure control.

Long‑Term Cardiovascular Protection

CIDNITAB T 20/40 supports a comprehensive hypertension management plan by:

• Reducing arterial stiffness

• Improving endothelial function

• Preventing cardiovascular events

• Protecting vital organs

Long‑term use under medical guidance ensures sustained benefits.

Conclusion

CIDNITAB T 20/40 represents a modern, effective, and patient‑friendly solution for hypertension management. By combining the vasodilatory benefits of Cilnidipine with the renoprotective and cardiovascular advantages of Telmisartan, it delivers comprehensive blood pressure control with improved safety and tolerability.

Frequently Asked Questions (FAQs)

Is CIDNITAB T 20/40 suitable for long‑term use?

Yes, it is designed for long‑term hypertension management under physician supervision.

Can it be taken once daily?

Yes, once‑daily dosing provides 24‑hour blood pressure control.

Does it cause rapid heartbeat?

Cilnidipine causes less reflex tachycardia compared to older calcium channel blockers.

Can diabetic patients take CIDNITAB T 20/40?

Yes, it is particularly beneficial for hypertensive patients with diabetes.

If You Want To Purchase The Product Click Here.

We Have Our Cardiology Range.

From quality and niche products STERIS HEALTHCARE PVT LTD grow rapidly in all segments. STERIS HEALTHCARE products range covers almost every cadre of requirement in today's Medical scenario, widely prescribed under categories like Cardiology, Asthama, Respiratory, Nasal, Diabetic, Endocrinology, Cardiology, Gastrology, Orthopaedic, Anti-infective/antibiotic, General, Urology, Neurology, Nephrology, Oncology, Gynaecology, Pediatric, Dental & Derma range of Products. We have been around for more than 8 years. However, within a short span of time STERIS HEALTHCARE has increase his product range from 0 to 1800+ in Seven years. STERIS is careful to balance growth with the unshakable quality assurance systems for which the company is now recognized, the founders were quickly able to broaden their footprint in the market, increasing access to high-quality Healthcare for people across the globe, at every stage of life.